Skip to content
value.today
Cell Source, Inc. logo

Cell Source, Inc.

Cell Source, Inc. is listed today as Cell Source, Inc.: market value, financials and filings are on its company page.

Funding rounds

0 counted as startup funding, 2 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Cell Source, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2020$4 MPrivate placement after listing$2 to $10 million

Cell Source, Inc.: Private sale, Dec 2020

Investors in this round

48 investors had bought by the notice of Oct 6, 2023: 48 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Cell Source, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$4 M (amount offered: indefinite)
Smallest investment taken
$25,000
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
$411,740 (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Nevada

People named in the notice

  • Itamar Shimrat · Executive Officer
  • Darlene Soave · Director · Represents salary paid to the President and Chief Executive Officer of the Issuer in 2021 and 2022.
  • Dennis Brown · Director
  • George Verstraete · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Represents salary paid to the President and Chief Executive Officer of the Issuer in 2021 and 2022.”

Signed by Itamar Shimrat, President. Source: SEC Form D, newest notice filed Oct 6, 2023. Read the notice at the SEC.

debt, optionsSEC
Sep 2016$9 MPrivate placement after listing$2 to $10 million

Cell Source, Inc.: Private sale, Sep 2016

Investors in this round

62 investors had bought by the notice of Oct 18, 2019: 62 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Cell Source, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$9 M of $10 M offered; $1 M still to sell
Smallest investment taken
$25,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
$700,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Nevada

People named in the notice

  • Itamar Shimrat · Executive Officer, Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Itamar Shimrat, President & CEO. Source: SEC Form D, newest notice filed Oct 18, 2019. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Cell Source, Inc. had no revenue when it filed its newest notice of a funding round (Oct 2023).

    SEC Form D (revenue range) · Oct 2023

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Oct 2023

Products and services#

No products or services of Cell Source, Inc. are on record.

Investors#

1 named in official filings. Open an investor to see everything it has backed.

Investors in Cell Source, Inc.
InvestorKindAmountRoundRoleSource
Darlene SoavePersonnot statednot statedHeld Series A preferred stock, director (Form 3, 2021)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete.

Largest shareholders today

Institutions holding Cell Source, Inc. shares, as of Sep 30, 2026.

  • Planning Project LLC$0 M—

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Cell Source, Inc.
NameRoleNamed in
Itamar ShimratExecutive officerOct 2023
Darlene SoaveRepresents salary paid to the President and Chief Executive Officer of the Issuer in 2021 and 2022.Oct 2023
Dennis BrownDirectorOct 2023
George VerstraeteDirectorOct 2023
Itamar ShimratDirectorOct 2019

Went public since 2015. Its SEC number is that of a company listed on a stock exchange.